Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31985399.
- Also identified by DOI 10.7554/eLife.52189 and PMC identifier 7053997.
- Licence recorded as CC0.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
By analyzing and simulating inactive conformations of the highly homologous dopamine D<sub>2</sub> and D<sub>3</sub> receptors (D<sub>2</sub>R and D<sub>3</sub>R), we find that eticlopride binds D<sub>2</sub>R in a pose very similar to that in the D<sub>3</sub>R/eticlopride structure but incompatible with the D<sub>2</sub>R/risperidone structure. In addition, risperidone occupies a sub-pocket near the Na<sup>+</sup> binding site, whereas eticlopride does not. Based on these findings and our experimental results, we propose that the divergent receptor conformations stabilized by Na<sup>+</sup>-sensitive eticlopride and Na<sup>+</sup>-insensitive risperidone correspond to different degrees of inverse agonism. Moreover, our simulations reveal that the extracellular loops are highly dynamic, with spontaneous transitions of extracellular loop 2 from the helical conformation in the D<sub>2</sub>R/risperidone structure to an extended conformation similar to that in the D<sub>3</sub>R/eticlopride structure. Our results reveal previously unappreciated diversity and dynamics in the inactive conformations of D<sub>2</sub>R. These findings are critical for rational drug discovery, as limiting a virtual screen to a single conformation will miss relevant ligands.
Medical subject headings
- Dopamine Agonists
- Dopamine Antagonists
- Receptors, Dopamine D2
- Receptors, Dopamine D3